SMTL ID : 6vnh.2 (1 other biounit)

JAK2 JH1 in complex with PN2-123

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x XZS: N-{5-[(2-{[3,5-difluoro-4-(1-methylpiperidin-4-yl)phenyl]amino}-5-methylpyrimidin-4-yl)amino]-2-fluorophenyl}-2-methylpropane-2-sulfonamide(Non-covalent)

XZS.1: 17 residues within 4Å: Chain A: L.31, G.32, K.33, G.34, V.39, A.56, K.58, M.105, E.106, Y.107, L.108, P.109, G.111, N.157, L.159, G.169, D.170 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.31, A:L.31, A:V.39, A:A.56, A:Y.107, A:L.159 Hydrogen bonds: A:L.108, A:L.108, A:N.157

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Davis, R.R. et al., Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof. J.Med.Chem. (2021)

Release Date

2021-02-17

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence